KeyBank National Association’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $593K | Sell |
10,499
-2,637
| -20% | -$154K | ﹤0.01% | 755 |
|
|
2025
Q4 | $781K | Sell |
13,136
-5,492
| -29% | -$299K | ﹤0.01% | 647 |
|
|
2025
Q3 | $1.01M | Sell |
18,628
-9,357
| -33% | -$535K | ﹤0.01% | 573 |
|
|
2025
Q2 | $1.54M | Sell |
27,985
-19,707
| -41% | -$1.16M | 0.01% | 487 |
|
|
2025
Q1 | $3.37M | Sell |
47,692
-21,892
| -31% | -$1.47M | 0.01% | 339 |
|
|
2024
Q4 | $4.57M | Sell |
69,584
-92,757
| -57% | -$6.21M | 0.02% | 301 |
|
|
2024
Q3 | $11.4M | Sell |
162,341
-243,529
| -60% | -$20.4M | 0.04% | 217 |
|
|
2024
Q2 | $33.4M | Sell |
405,870
-154,609
| -28% | -$12.9M | 0.14% | 130 |
|
|
2024
Q1 | $49M | Sell |
560,479
-60,479
| -10% | -$5.41M | 0.2% | 105 |
|
|
2023
Q4 | $59.9M | Buy |
620,958
+10,072
| +2% | +$891K | 0.27% | 81 |
|
|
2023
Q3 | $54.1M | Buy |
610,886
+20,884
| +4% | +$1.86M | 0.26% | 86 |
|
|
2023
Q2 | $51.1M | Buy |
590,002
+28,952
| +5% | +$2.72M | 0.23% | 91 |
|
|
2023
Q1 | $54.6M | Buy |
561,050
+28,014
| +5% | +$2.9M | 0.26% | 84 |
|
|
2022
Q4 | $55.2M | Buy |
533,036
+33,769
| +7% | +$3.17M | 0.27% | 84 |
|
|
2022
Q3 | $42.3M | Buy |
499,267
+29,027
| +6% | +$2.58M | 0.22% | 100 |
|
|
2022
Q2 | $39M | Buy |
470,240
+89,340
| +23% | +$7.11M | 0.19% | 108 |
|
|
2022
Q1 | $29.4M | Buy |
380,900
+76,189
| +25% | +$6.37M | 0.12% | 146 |
|
|
2021
Q4 | $26.9M | Buy |
304,711
+125,229
| +70% | +$10.3M | 0.11% | 148 |
|
|
2021
Q3 | $13.9M | Buy |
179,482
+3,079
| +2% | +$243K | 0.06% | 189 |
|
|
2021
Q2 | $14.7M | Buy |
176,403
+16,632
| +10% | +$1.32M | 0.06% | 183 |
|
|
2021
Q1 | $12.1M | Buy |
159,771
+94,281
| +144% | +$7.7M | 0.06% | 191 |
|
|
2020
Q4 | $5.74M | Buy |
65,490
+53,541
| +448% | +$4.24M | 0.03% | 249 |
|
|
2020
Q3 | $909K | Buy |
11,949
+2,001
| +20% | +$202K | ﹤0.01% | 515 |
|
|
2020
Q2 | $1.23M | Buy |
9,948
+1,800
| +22% | +$179K | 0.01% | 413 |
|
|
2020
Q1 | $689K | Sell |
8,148
-1,548
| -16% | -$133K | ﹤0.01% | 537 |
|
|
2019
Q4 | $820K | Buy |
+9,696
| New | +$732K | ﹤0.01% | 596 |
|
|
2019
Q3 | – | Sell |
-3,754
| Closed | -$322K | – | 989 |
|
|
2019
Q2 | $322K | Sell |
3,754
-2,682
| -42% | -$229K | ﹤0.01% | 845 |
|
|
2019
Q1 | $572K | Sell |
6,436
-777
| -11% | -$72K | ﹤0.01% | 686 |
|
|
2018
Q4 | $614K | Buy |
7,213
+1,633
| +29% | +$155K | ﹤0.01% | 618 |
|
|
2018
Q3 | $541K | Sell |
5,580
-5,115
| -48% | -$511K | ﹤0.01% | 747 |
|
|
2018
Q2 | $1.01M | Buy |
10,695
+5,812
| +119% | +$509K | 0.01% | 543 |
|
|
2018
Q1 | $396K | Sell |
4,883
-1,329
| -21% | -$114K | ﹤0.01% | 807 |
|
|
2017
Q4 | $554K | Sell |
6,212
-1,594
| -20% | -$139K | ﹤0.01% | 721 |
|
|
2017
Q3 | $727K | Buy |
7,806
+2,836
| +57% | +$251K | ﹤0.01% | 666 |
|
|
2017
Q2 | $451K | Sell |
4,970
-2,803
| -36% | -$255K | ﹤0.01% | 846 |
|
|
2017
Q1 | $682K | Buy |
7,773
+1,895
| +32% | +$169K | ﹤0.01% | 724 |
|
|
2016
Q4 | $487K | Buy |
5,878
+1,589
| +37% | +$137K | ﹤0.01% | 821 |
|
|
2016
Q3 | $397K | Sell |
4,289
-890
| -17% | -$83.8K | ﹤0.01% | 895 |
|
|
2016
Q2 | $403K | Buy |
+5,179
| New | +$440K | ﹤0.01% | 851 |
|
|
2016
Q1 | – | Sell |
-4,600
| Closed | -$482K | – | 1107 |
|
|
2015
Q4 | $482K | Buy |
4,600
+2,114
| +85% | +$221K | ﹤0.01% | 783 |
|
|
2015
Q3 | $262K | Sell |
2,486
-3,540
| -59% | -$473K | ﹤0.01% | 990 |
|
|
2015
Q2 | $824K | Sell |
6,026
-196
| -3% | -$24.3K | 0.01% | 667 |
|
|
2015
Q1 | $775K | Buy |
+6,222
| New | +$659K | 0.01% | 713 |
|
|
2014
Q3 | – | Sell |
-7,099
| Closed | -$442K | – | 1232 |
|
|
2014
Q2 | $442K | Buy |
7,099
+1,621
| +30% | +$97.9K | ﹤0.01% | 939 |
|
|
2014
Q1 | $374K | Sell |
5,478
-426
| -7% | -$31.4K | ﹤0.01% | 1009 |
|
|
2013
Q4 | $415K | Buy |
5,904
+500
| +9% | +$34K | ﹤0.01% | 974 |
|
|
2013
Q3 | $390K | Sell |
5,404
-900
| -14% | -$59.8K | ﹤0.01% | 954 |
|
|
2013
Q2 | $351K | Buy |
+6,304
| New | +$393K | ﹤0.01% | 1089 |
|
Other funds holding BMRN
VCM
VPM
